Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
13.67
-0.60 (-4.21%)
Market open: Aug 12, 2026, 12:28 PM EDT
14.27
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:51 PM EDT
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
| Name | Position |
|---|---|
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board |
| Mr. Amnon Gat | Chief Operations Officer |
| Mr. Raphi Levy | Chief Financial Officer |
| Mr. Ronen Segal | Chief Technology Officer |
| Mr. Uzi Sofer | CEO & Chairman |
| Ms. Rebecca Becker | Vice President of legal |
| Ms. Yael Zeiger | Corporate Controller |
| Prof. Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board |
| Date | Type | Document |
|---|---|---|
| 2026-08-10 | 6-K | ea0301309-6k_alpha.htm |
| 2026-07-21 | 6-K | ea0298609-6k_alpha.htm |
| 2026-07-15 | 6-K | ea0297988-6k_alpha.htm |
| 2026-06-25 | 6-K | ea0295961-6k_alpha.htm |
| 2026-06-23 | 6-K | ea0295467-6k_alpha.htm |
| 2026-06-11 | 6-K | ea0294458-6k_alpha.htm |
| 2026-06-03 | 6-K | ea0293331-6k_alpha.htm |
| 2026-06-01 | 6-K | ea0292770-6k_alpha.htm |
| 2026-05-18 | 6-K | ea0290584-6k_alpha.htm |
| 2026-05-11 | 6-K | ea0290058-6k_alpha.htm |